Brimpharm specialises in the sourcing of product from manufacturers around the world for registration and marketing in its key markets, primarily South Africa (covering the continent of Africa), Australia and New Zealand.

Established in 1998, Brimpharm began by working with Chinese manufacturers and its main focus being the collaborative development of products for registration in regulated markets. It now represents several manufacturers in China, having obtained GMP approvals from TGA and MCC for its manufacturing sites. Brimpharm has an office in Shanghai that compiles CTD format dossiers, prepares facilities for GMP audits and manages the supply chain and business relationships.